AAAAAA

   
Results: 1-15 |
Results: 15
COMPLEMENTARY AND ALTERNATIVE MEDICINE - EVALUATING ITS EFFECTIVENESSIN INFLAMMATORY BOWEL-DISEASE
Authors: HILSDEN RJ VERHOEF MJ
Citation: Rj. Hilsden et Mj. Verhoef, COMPLEMENTARY AND ALTERNATIVE MEDICINE - EVALUATING ITS EFFECTIVENESSIN INFLAMMATORY BOWEL-DISEASE, Inflammatory bowel diseases, 4(4), 1998, pp. 318-323
SAFETY AND TOLERABILITY OF HIGH-DOSE ORAL PREDNISONE IN THE TREATMENTOF MULTIPLE-SCLEROSIS
Authors: METZ LM SABUDA D ENNS R BECK PL MEDDINGS JB CURRIE G HILSDEN RJ
Citation: Lm. Metz et al., SAFETY AND TOLERABILITY OF HIGH-DOSE ORAL PREDNISONE IN THE TREATMENTOF MULTIPLE-SCLEROSIS, Neurology, 50(4), 1998, pp. 4007-4007
IS THERE BIAS IN THE SELECTION OF ABSTRACTS FOR PRESENTATION AT THE DDW
Authors: TIMMER A MACARTHUR C HILSDEN RJ BRASHER P COLE JH HAILEY D SUTHERLAND LR
Citation: A. Timmer et al., IS THERE BIAS IN THE SELECTION OF ABSTRACTS FOR PRESENTATION AT THE DDW, Gastroenterology, 114(4), 1998, pp. 186-186
INFORMATION NEEDS AND SEEKING BEHAVIORS OF PATIENTS WITH INFLAMMATORYBOWEL-DISEASE
Authors: HILSDEN RJ DUNN C PATTEN S SCOTT CM VERHOEF MJ
Citation: Rj. Hilsden et al., INFORMATION NEEDS AND SEEKING BEHAVIORS OF PATIENTS WITH INFLAMMATORYBOWEL-DISEASE, Gastroenterology, 114(4), 1998, pp. 4078-4078
COMPLEMENTARY MEDICINE USE BY PATIENTS WITH INFLAMMATORY BOWEL-DISEASE
Authors: HILSDEN RJ SCOTT CM VERHOEF MJ
Citation: Rj. Hilsden et al., COMPLEMENTARY MEDICINE USE BY PATIENTS WITH INFLAMMATORY BOWEL-DISEASE, The American journal of gastroenterology, 93(5), 1998, pp. 697-701
RESEARCH AND THE INTERNET
Authors: HILSDEN RJ SCOTT CM VERHOEF MJ
Citation: Rj. Hilsden et al., RESEARCH AND THE INTERNET, The American journal of gastroenterology, 93(3), 1998, pp. 484-485
INTESTINAL PERMEABILITY (IP) BEFORE AND AFTER IBUPROFEN IN FAMILIES OF CHILDREN WITH CROHNS-DISEASE
Authors: ZAMORA SA SCOTT RB BUTZNER DJ HILSDEN RJ MEDDINGS JB SUTHERLAND LR
Citation: Sa. Zamora et al., INTESTINAL PERMEABILITY (IP) BEFORE AND AFTER IBUPROFEN IN FAMILIES OF CHILDREN WITH CROHNS-DISEASE, Gastroenterology, 112(4), 1997, pp. 1127-1127
CHOLECYSTECTOMY ALSO ON RISE IN ALBERTA
Authors: HILSDEN RJ SHAFFER EA
Citation: Rj. Hilsden et Ea. Shaffer, CHOLECYSTECTOMY ALSO ON RISE IN ALBERTA, CMAJ. Canadian Medical Association journal, 155(2), 1996, pp. 161-162
MEDICAL AND NUTRITIONAL THERAPY FOR CROHNS-DISEASE
Authors: HILSDEN RJ SUTHERLAND LR
Citation: Rj. Hilsden et Lr. Sutherland, MEDICAL AND NUTRITIONAL THERAPY FOR CROHNS-DISEASE, Current opinion in gastroenterology, 12(4), 1996, pp. 356-362
INTESTINAL PERMEABILITY CHANGES IN RESPONSE TO ACETYLSALICYLIC-ACID IN RELATIVES OF PATIENTS WITH CROHNS-DISEASE
Authors: HILSDEN RJ MEDDINGS JB SUTHERLAND LR
Citation: Rj. Hilsden et al., INTESTINAL PERMEABILITY CHANGES IN RESPONSE TO ACETYLSALICYLIC-ACID IN RELATIVES OF PATIENTS WITH CROHNS-DISEASE, Gastroenterology, 110(5), 1996, pp. 1395-1403
CHOLECYSTECTOMY UTILIZATION - A POPULATION-BASED STUDY IN A SETTING OF UNIVERSAL HEALTH-INSURANCE
Authors: HILSDEN RJ SHAFFER EA
Citation: Rj. Hilsden et Ea. Shaffer, CHOLECYSTECTOMY UTILIZATION - A POPULATION-BASED STUDY IN A SETTING OF UNIVERSAL HEALTH-INSURANCE, Gastroenterology, 110(4), 1996, pp. 20-20
INTESTINAL PERMEABILITY AND PLASMA DIAMINE OXIDASE ACTIVITY IN THE PREDICTION OF CROHNS-DISEASE RELAPSE
Authors: HILSDEN RJ MEDDINGS JB GALL DG HARDIN JA SUTHERLAND LR
Citation: Rj. Hilsden et al., INTESTINAL PERMEABILITY AND PLASMA DIAMINE OXIDASE ACTIVITY IN THE PREDICTION OF CROHNS-DISEASE RELAPSE, Gastroenterology, 110(4), 1996, pp. 924-924
ASPIRIN PROVOKES AN EXAGGERATED INCREASE IN THE LACTULOSE MANNITOL PERMEABILITY INDEX IN 1ST-DEGREE RELATIVES OF CROHNS PATIENTS
Authors: HILSDEN RJ MEDDINGS J SUTHERLAND LR
Citation: Rj. Hilsden et al., ASPIRIN PROVOKES AN EXAGGERATED INCREASE IN THE LACTULOSE MANNITOL PERMEABILITY INDEX IN 1ST-DEGREE RELATIVES OF CROHNS PATIENTS, Gastroenterology, 108(4), 1995, pp. 834-834
MANAGEMENT OF GASTROINTESTINAL HEMORRHAGE
Authors: HILSDEN RJ SHAFFER EA
Citation: Rj. Hilsden et Ea. Shaffer, MANAGEMENT OF GASTROINTESTINAL HEMORRHAGE, Canadian family physician, 41, 1995, pp. 1931
END-STAGE LIVER-DISEASE DEVELOPING WITH THE USE OF METHOTREXATE IN HETEROZYGOUS ALPHA(1)-ANTITRYPSIN DEFICIENCY
Authors: HILSDEN RJ URBANSKI SJ SWAIN MG
Citation: Rj. Hilsden et al., END-STAGE LIVER-DISEASE DEVELOPING WITH THE USE OF METHOTREXATE IN HETEROZYGOUS ALPHA(1)-ANTITRYPSIN DEFICIENCY, Arthritis and rheumatism, 38(7), 1995, pp. 1014-1018
Risultati: 1-15 |